A Clinical Cohort Study of Pneumonia in Respiratory Intensive Care Unit
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02738645 |
|
Recruitment Status :
Recruiting
First Posted : April 14, 2016
Last Update Posted : March 30, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment |
|---|---|
| Pneumonia | Other: pneumonia |
| Study Type : | Observational |
| Estimated Enrollment : | 800 participants |
| Observational Model: | Cohort |
| Time Perspective: | Other |
| Official Title: | A Clinical Cohort Study of Pneumonia in Respiratory Intensive Care Unit |
| Study Start Date : | June 2016 |
| Estimated Primary Completion Date : | December 2022 |
| Estimated Study Completion Date : | December 2022 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
pneumonia in RICU
The patients admit in RICU because of pneumonia.
|
Other: pneumonia |
- the mortality caused by any reasons in RICU [ Time Frame: one years ]
- the morbidity caused by any reasons in RICU [ Time Frame: one years ]
- the symptoms description of pneumonia caused by any reasons in RICU [ Time Frame: the first 48hours after admitted in RICU ]all the symptoms caused by pneumonia, such as fever, cough, dyspnea, sputum and so on. The investigators could get the incidence of each of these symptoms.
- the respiratory support of pneumonia caused by any reasons in RICU [ Time Frame: the first 5 days after admitted in RICU ]summarize the respiratory support parameters while the patients hospitalized in RICU. For example, the ventilation parameter and mode, Whether the mechanical ventilation complications occurred, and so on.
- the treatment options of pneumonia caused by any reasons in RICU [ Time Frame: 3 weeks ]the investigators obtain the treatment commons, such as the kind of antibiotics, the dosage of glucocorticoids, etc.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- admit in RICU because of pneumonia of any causes
- anticipated length of hospital stay more than 72h
Exclusion Criteria:
- admit in RICU because of other causes except pneumonia
- do not agree to join this study
- admit in RICU for the second time
- anticipated length of hospital stay less than 72h
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02738645
| Contact: Bing Sun, Dr | 86013911151075 | ricusunbing@126.com | |
| Contact: Xiao Tang, Dr | 86013811089795 | tangxiao0928@163.com |
| China, Beijing | |
| Department of respiratory and critical care medicine,Beijing Chao-yang Hospital | Recruiting |
| Beijing, Beijing, China, 100020 | |
| Contact: Bing Sun, MD 86013911151075 ricusunbing@126.com | |
| Contact: Xiao Tang, MD 86013811089795 tangxiao0928@163.com | |
| Principal Investigator: Bing Sun, MD | |
| Principal Investigator: | Bing Sun, Dr | Beijing Chao-Yang Hospital, China |
| Responsible Party: | Xiao Tang, Dr, Beijing Chao Yang Hospital |
| ClinicalTrials.gov Identifier: | NCT02738645 |
| Other Study ID Numbers: |
Pneumonia RICU |
| First Posted: | April 14, 2016 Key Record Dates |
| Last Update Posted: | March 30, 2021 |
| Last Verified: | March 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
|
Pneumonia Respiratory Tract Infections Infections Lung Diseases Respiratory Tract Diseases |

